GEMMES VENTURE

About GEMMES VENTURE

Philippe Monnot is a French executive and investor best known for his role as co-leader of GEMMES VENTURE, the investment firm he co-founded in 1999. He is a graduate of EM Lyon and has built a career around backing innovative companies with a strong focus on healthcare, digital services, fintech, and cleantech. GEMMES VENTURE is described as a founding member of several healthcare-related businesses, including ASTEN SANTÉ, H2AD TELEHEALTH, and VIVALIB, reflecting a long-term investment philosophy centered on company building rather than passive ownership. In listed-company governance, Monnot is most visibly associated with CROSSJECT, where GEMMES VENTURE has long been the reference shareholder and where he serves as Chairman of the Supervisory Board. CROSSJECT’s governance materials and financing announcements repeatedly emphasize GEMMES VENTURE’s support, including its participation in the company’s 2024 and 2025 capital increases and its continued backing of the business through multiple funding rounds. This makes Monnot a key figure not only as an investor but also as a governance anchor for the company’s strategic and financial development. His profile highlights deep experience in growth capital, shareholder support, and the governance of innovative healthcare businesses at critical development stages. Through GEMMES VENTURE, Monnot has helped finance and support entrepreneurial projects in medical and technology-driven sectors, combining strategic patience with active oversight. At CROSSJECT in particular, his role has been associated with recurring financial commitment, institutional credibility, and long-term alignment with management as the company advances its industrial and regulatory agenda.